Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Sanofi sales lifted by diabetes and rare diseases

February 6, 2015 Sales and Marketing Genzyme, Lantus, Sanofi, diabetes, financials, insulin glargine, praluent, q4

Sanofi racked up €7.4 billion in sales in the fourth quarter of 2014 according to the company’s latest financials report. …
News

NHS reform was ‘distracting and damaging’

February 6, 2015 Sales and Marketing CDF, Cameron, NHS, UK, coalition, healthcare, king's fund

Healthcare think tank The King’s Fund has said through a report that organisational changes to the NHS under the coalition …
News

AstraZeneca looks for revenue boost via Actavis buy

February 6, 2015 Sales and Marketing Actavis, AstraZeneca, Brilinta, Forxiga, diabetes, fourth quarter, q4

AstraZeneca recorded a dip in revenue in the last quarter of 2014 and is looking to ramp up its respiratory …
News

Flu vaccine ineffective against this season’s strain

February 6, 2015 Research and Development, Sales and Marketing A(H3N2, Public Health England, UK, Vaccine, WHO, flu, phe

This season’s flu vaccine has provided little protection against the main strain circulating in the UK according to a new …
News

US hospitals trial Apple’s HealthKit

February 6, 2015 Medical Communications, Sales and Marketing Apple, Health Mate, Motion 24/7 Sleeptracker, Samsung, google, healthkit, wearables

A pilot programme for Apple’s mobile health platform HealthKit has been rolled out across a number of US hospitals to …
News

Martindale Pharma appoints sales director

February 6, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing eric vick, martindale pharma

UK speciality pharma firm Martindale Pharma has appointed Eric Vick to be its group director of international sales. Eric has …
Appointment

FDA commissioner steps down in March

February 5, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew von Eschenbach, FDA, Margaret Hamburg, Obama, Stephen Ostroff, US

The commissioner of the US Food and Drug Administration Dr Margaret Hamburg is to resign from her post at the …
News

Pharma adverse event FDA reports are inadequate

February 5, 2015 Sales and Marketing FDA, Gilead, Solvaldi, US Institute for Safe Medication Practices, pharma, sofosbuvir

Reports of adverse drug events submitted to the FDA by pharma firms are often incomplete and lacking in detail, a …
News

Pfizer to buy Hospira for $17 billion

February 5, 2015 Sales and Marketing Hospira, Humira, Pfizer, acquisition, biosimilars, merger

Pfizer has struck a deal with Hospira to acquire the company in a deal worth around $17 billion. Industry analysts …
News

Late-stage successes for Amgen and Roche

February 5, 2015 Sales and Marketing Amgen, Bendamustine, Gazyva, Genentech, Humira, Levact, Napp, Roche, adalimumab, obinutuzumab

Roche and Amgen have both posted successful late-stage trial results that they say will contribute to their applications for regulatory …
News

GSK blames respiratory woes as sales drop

February 5, 2015 Sales and Marketing Advair, GSK, GlaxoSmithKline, HIV, ViiV, Witty, anoro ellipta, breo, lovaza, q4, sales

GlaxoSmithKline’s respiratory business has been flagged as the key factor in the firm’s fourth quarter financial misfortunes, as its total …
News

Pfizer gets early approval for breast cancer drug

February 4, 2015 Sales and Marketing FDA, Pfizer, Xalkori (crizotinib), axitinib, bosulif, bosutinib, femara, ibrance, inlyta, letrozole, palbociclib

The FDA has shown Pfizer’s breast cancer drug Ibrance an early green light to treat patients who are at the …
News

Gilead sales soar on back of hepatitis drugs

February 4, 2015 Sales and Marketing Atripla, Gilead, efavirenz, emtricitabine, harvoni, lepidasvir, q4, sofosbuvir, sovaldi, tenofovi

The new blockbuster hepatitis C treatments Sovaldi and Harvoni more than doubled Gilead’s sales in the last quarter of 2014 …
News

Half of UK population will get cancer

February 4, 2015 Research and Development, Sales and Marketing CDF, CRUK, Cancer, Jevtana, Sanofi, cabazitaxel

New figures from Cancer Research UK (CRUK) suggest that one in two people will develop cancer at some point in …
News

Merck releases insomnia drug in US

February 4, 2015 Sales and Marketing FDA, Merck, belsomra, insomnia, orexin, suvorexant

Merck’s insomnia drug Belsomra is now available in the US to treat patients who have difficulty falling asleep or staying …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026